MIT Enterprise Forum Innovation Series Event: Pushing the Limits of Lifespan, from Innovation to Commercialization

• 5.7.2015 - 5.8.2015
• The Broad Institute 415 Main Street Cambridge, MA 02142

Life extending technologies and research are evolving exponentially, from induced pluripotent stem cells (IPS), pharmacogenomics and embedded technologies to naturally derived alternative therapies and holistic approaches. In this climate, investors and consumers are left to perform high-stakes due diligence that can influence both the financial success of a company and also one’s individual health.

This event brings together both internationally renowned researchers and leading life science investors for a conversation that explores the fascinating field of life extension, its potential for monetization and role in challenging humanity’s greatest adversary, mortality itself.